6.1.2.3: Other antidiabetic drugs

Part of chapter 6 Endocrine System, section 6.1 Drugs used in diabetes

High-level prescribing trends for Other antidiabetic drugs (BNF section 6.1.2.3) across The New Seaham Medical Group for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Acarbose (0601023A0)
Albiglutide (0601023AS)
Alogliptin (0601023AK)
Alogliptin/metformin (0601023AJ)
Canagliflozin (0601023AM)
Canagliflozin/metformin (0601023AP)
Dapagliflozin (0601023AG)
Dapagliflozin/metformin (0601023AL)
Dulaglutide (0601023AQ)
Empagliflozin (0601023AN)
Empagliflozin/linagliptin (0601023AY)
Empagliflozin/metformin (0601023AR)
Ertugliflozin (0601023AX)
Exenatide (0601023Y0)
Guar gum (0601023I0)
Ins degludec/liraglutide (0601023AU)
Linagliptin (0601023AE)
Linagliptin/metformin (0601023AF)
Liraglutide (0601023AB)
Lixisenatide (0601023AI)
Metformin hydrochloride/pioglitazone (0601023W0)
Metformin hydrochloride/rosiglitazone (0601023V0)
Metformin hydrochloride/sitagliptin (0601023AD)
Metformin hydrochloride/vildagliptin (0601023Z0)
Nateglinide (0601023U0)
Pioglitazone hydrochloride (0601023B0)
Repaglinide (0601023R0)
Rosiglitazone (0601023S0)
Saxagliptin (0601023AC)
Saxagliptin/dapagliflozin (0601023AV)
Saxagliptin/metformin (0601023AH)
Semaglutide (0601023AW)
Sitagliptin (0601023X0)
Tirzepatide (0601023AZ)
Vildagliptin (0601023AA)
Feedback